Exercise for hereditary ATTR amyloidosis in Portugal
Part of Heart & circulation clinical trials.
This trial tests whether a structured exercise program can help people with hereditary ATTR amyloidosis (a condition that affects nerves and organs). It is for people in Portugal with early to moderate disease who can safely exercise.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with hereditary ATTR (ATTRv) amyloidosis.
- You live in Portugal.
- Your disease is at stage 1 or 2 (mild to moderate).
- You have not had a liver transplant in the past 6 months.
- Your doctor says it is safe for you to exercise.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a structured exercise training program is safe and helpful for people with transthyretin (ATTR) cardiac amyloidosis. It may help improve fitness and daily functioning, and it may also compare groups for specific eligibility needs.
This study tests whether a supervised exercise and rehabilitation program can help people with a specific type of heart amyloidosis (ATTRwt) feel better and improve their heart function. It may be a good fit if you have stable heart failure and can safely exercise.
This study tests whether a program of exercise and special nutritional supplements can help people aged 70 and older with transthyretin cardiac amyloidosis—a condition where abnormal proteins build up in the heart. It aims to see if this combination can improve heart function and quality of life.
This study looks at how a specific genetic change (Val50Met) affects people with hereditary ATTR amyloidosis. It may help doctors better understand the condition and its symptoms.
This study tests a structured psychological support program for people with hereditary transthyretin amyloidosis (ATTRv) with heart involvement, their caregivers, and those who carry the gene but have no symptoms yet. The goal is to see if the program is practical and well-accepted.
This study looks at whether a 5-week supervised exercise and education program can help people with a specific type of heart amyloidosis (ATTR) feel better and improve their heart function. It will check your exercise ability and heart health before and after the program.
Hear when a new Amyloidosis, Hereditary, Transthyretin-Related trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.